- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00027352
En sammenligning av to måter å håndtere anti-HIV-behandling på (SMART-studien)
En stor, enkel studie som sammenligner to strategier for behandling av antiretroviral terapi (SMART-studien)
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Implementering av retningslinjer for antiretroviral behandling (ART), som legger vekt på maksimal og varig undertrykkelse av viral belastning for de fleste individer som er infisert med HIV, har resultert i en betydelig nedgang i sykelighet og dødelighet. Mange asymptomatiske pasienter har imidlertid ikke umiddelbar risiko for alvorlige opportunistiske sykdommer, effektiviteten av ART avtar over tid på grunn av HIV-resistens, og det er kort- og langsiktige toksisiteter ved behandling. Dette motiverer en sammenligning av to strategier: en som sparer behandlinger ved å utsette bruken mens risikoen for opportunistisk sykdom er lav og en som tar sikte på vedvarende virologisk undertrykkelse, uavhengig av sykdomsrisiko.
I denne store, langsiktige studien vil pasienter bli tilfeldig tildelt enten gruppen medikamentkonservering (DC) eller viral undertrykkelse (VS). Pasienter vil bli registrert over en 3-års periode og fulgt i gjennomsnitt 7,5 år. DC-gruppen vil stoppe eller utsette ART til CD4-celletallet synker til under 250 celler/mm3; de vil deretter motta behandling for å øke CD4-tallet til mer enn 350 celler/mm3 etterfulgt av episodisk ART basert på CD4-celletallet. VS-gruppen vil bruke ART for å holde virusmengden så lav som mulig, uavhengig av CD4-celletall. Pasienter vil bli sett måned 1, 2, 4, 6, 8, 10 og 12, deretter hver 4. måned for datainnsamlingsbesøk. Alle tilgjengelige ART-er, inkludert immunmodulatorer, og resistenstesting kan brukes av pasienter i begge behandlingsgruppene. Utvalgte delprøver av pasienter som er registrert i studien vil bli fulgt med mer intensiv datainnsamling for sekundære utfall knyttet til kostnader og bruk av helsetjenester, livskvalitet, risikoatferd for HIV-overføring og metabolske komplikasjoner ved behandling.
Studietype
Registrering
Kontakter og plasseringer
Studiesteder
-
-
-
Buenos Aires, Argentina
- Hospital Italiano de Buenos Aires
-
Buenos Aires, Argentina
- Hospital de Clinicas Jose de San Martin
-
Buenos Aires, Argentina
- Hospital de Infecciosas F.J. Muniz
-
Buenos Aires, Argentina
- Hospital Gn'l de Agudos JM Ramos Mejia
-
Buenos Aires, Argentina
- Hospital Gn'l de Agudos T. Alvarez
-
Cordoba, Argentina
- Hospital Rawson
-
La Plata, Argentina
- Hospital Interzonall de San Juan de Dios
-
Mendoza, Argentina
- Hospital Central
-
Rosario, Argentina
- CAICI
-
-
-
-
-
Burwood Nsw, Australia, 2134
- Burwood Street General Pratice
-
Perth, Australia
- Royal Perth Hosp
-
Prahan, Australia
- Alfred Hosp
-
Prahan, Australia
- Royal Prince Alfred Hospital
-
Sydney, Australia
- National Centre in HIV Epidemiology and Clinical Research
-
-
South Australia
-
Adelaide, South Australia, Australia
- Royal Adelaide Hospital
-
-
Victoria
-
South Yarra, Victoria, Australia
- Prahran Market Clinic
-
South Yarra, Victoria, Australia
- The Centre Clinic
-
-
-
-
-
Antwerp, Belgia, 2000
- Institute of Tropical Medicine
-
Liege, Belgia, 4000
- Centre Hospitalier Universitaire Sart-Tilman
-
-
-
-
-
Boqueirao-Santos, Brasil, 11045-904
- Cassiano Antonio de Moraes University Hospital
-
Boqueirao-Santos, Brasil, 11045-904
- Centro de Pesquisa Clinical do Hospital Guilherme
-
Porto Alegre-RS Cep, Brasil, 90035
- Hospital de Clinicas de Porto Alegre
-
Rio de Janeiro, Brasil, 20221-903
- Hospital dos Servidores do Estado
-
Salvador-BA, Brasil, 110-160
- Hospital Universitario Professor Edgard Santos
-
San Paulo, Brasil, 04121-000
- Centro de Referência e Treinamento DST/AIDS
-
San Paulo, Brasil, 13083-970
- Unidade de Pesquisa Clínica
-
Sao Paulo, Brasil, 01246-900
- Ambulatorio de Imunodeficiencias Secundarias/Der30
-
Sao Paulo, Brasil, 04040-002
- Universidade Federal De Sao Paulo-Hospital Sao Paulo
-
-
RJ
-
Rio de Janeiro, RJ, Brasil, 20210.030
- Hospital Escola Sao Francisco de Asis
-
-
RS
-
Porto Alegre, RS, Brasil, 91350-200
- Hospital Nossa Senhora da Conceicao
-
-
S.p. Cep
-
Sao Paulo, S.p. Cep, Brasil, 01246
- Instituto de Infectologia Emilio Ribas
-
-
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2C7
- Downtown Infectious Disease Clinic
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, NS B3H 1V7
- Queen Elizabeth Ii Health Sciences Centre
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 3Z5
- Hamilton Health Science Centre-McMaster
-
London, Ontario, Canada, N5Y 3H6
- St. Joseph's Health Care Centre of London
-
London, Ontario, Canada
- St. Josephs Hospital
-
Sudbury, Ontario, Canada, P3E 5J1
- The HAVEN Program, HRSRH
-
Toronto, Ontario, Canada, M5G 2N2
- Tronto General Hospital
-
Windsor, Ontario, Canada, N8W 1E3
- HIV Care Program, Windsor Regional Hospital
-
-
Quebec
-
Fleurimont, Quebec, Canada, JIH 5N4
- University de Sherbrooke
-
Montreal, Quebec, Canada, H2L 4P9
- Clinique Médicale l'Actuel
-
Montreal, Quebec, Canada, H2X 2P4
- Montreal Chest Institute/Royal Victoria Hospital
-
Sainte-Foy, Quebec, Canada, F1V 4G2
- Centre Hospitalier de l'Université Laval (CHUL)
-
Ste-Foy, Quebec, Canada, G1V 4P9
- Recherche Clinique Centre Medical Halles de Saint-
-
-
-
-
-
Tallinn, Estland, 10617
- West-Tallinn Central Hospital
-
-
-
-
California
-
Fremont, California, Forente stater, 94538
- Kaiser Permanente-Fremont/Hayward Medical Centers
-
Los Angeles, California, Forente stater, 90015
- Aids Healthcare Foundation
-
Los Angeles, California, Forente stater, 90028
- Los Angeles Gay and Lesbian Community Service Ctr
-
San Francisco, California, Forente stater, 94110
- Community Consortium / UCSF
-
San Francisco, California, Forente stater, 94110
- Dr. Shawn Hassler
-
San Francisco, California, Forente stater, 94110
- East Bay AIDS Ctr
-
San Francisco, California, Forente stater, 94110
- Lawrence Goldyn, MD
-
-
Colorado
-
Denver, Colorado, Forente stater, 80204-4507
- Drs. Lichtenstein & Greenberg
-
Denver, Colorado, Forente stater, 80204-4507
- Western Infectious Disease Consultants
-
Denver, Colorado, Forente stater, 802044507
- Denver CPCRA / Denver Public Hlth
-
Denver, Colorado, Forente stater, 80204
- McDowell Healthcare Center
-
-
Connecticut
-
New Haven, Connecticut, Forente stater, 065102483
- Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit
-
New Haven, Connecticut, Forente stater, 06510
- Veterans Administration Medical Center
-
-
Delaware
-
Wilmington, Delaware, Forente stater, 19801
- Christiana Care Health Services HIV Program George
-
-
District of Columbia
-
Washington, District of Columbia, Forente stater, 204220001
- Timothy A Price
-
Washington, District of Columbia, Forente stater, 20422
- George Washington Univ
-
Washington, District of Columbia, Forente stater, 20422
- Washington Reg AIDS Prog / Dept of Infect Dis
-
-
Florida
-
Miami, Florida, Forente stater, 33125
- Miami Veterans Affairs Med Ctr
-
Pensacola, Florida, Forente stater, 32504
- Center for Prevention and Treatment of Infections
-
Vero Beach, Florida, Forente stater, 32960
- Treasure Coast Infectious Disease Consultants
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30308
- Absolute Care Clinic
-
Atlanta, Georgia, Forente stater, 30308
- AID Atlanta/Morehouse Med School Ryan White Cl
-
Atlanta, Georgia, Forente stater, 30308
- AIDS Research Consortium of Atlanta (ARCA) Central
-
Atlanta, Georgia, Forente stater, 30308
- Cobb-Douglas County Infectious Disease Clinic
-
Atlanta, Georgia, Forente stater, 30308
- Dekalb County Health Dept Infectious Disease
-
Atlanta, Georgia, Forente stater, 30308
- Dr. Dennis Melton (private practice)
-
Atlanta, Georgia, Forente stater, 30308
- Dr. Melanie Thompson and Dr. Annette Bernard (private practice)
-
Atlanta, Georgia, Forente stater, 30308
- Dr. Richard Hudson (private practice)
-
-
Idaho
-
Boise, Idaho, Forente stater, 83704
- HIV Services Clinic/Family Practice Medical Center
-
-
Illinois
-
Chicago, Illinois, Forente stater, 606576156
- Cook County Hosp
-
Chicago, Illinois, Forente stater, 606576156
- Klein and Slotten Associates / AIDS Research Alliance
-
Chicago, Illinois, Forente stater, 606576156
- Lakeshore Infectious Disease Associates
-
Chicago, Illinois, Forente stater, 606576156
- University of Illinois at Chicago
-
Chicago, Illinois, Forente stater, 60657
- AIDS Research Alliance - Chicago
-
Chicago, Illinois, Forente stater, 60657
- Northside Family Medicine
-
Chicago, Illinois, Forente stater, 60657
- Northwestern Memorial Physicians
-
Chicago, Illinois, Forente stater, 60657
- University of Chicago
-
Springfield, Illinois, Forente stater, 62702
- Southern Illinois University (SIU) School of Medicine
-
-
Kansas
-
Wichita, Kansas, Forente stater, 37214-3199
- KU Medical School-Wichita, Midtown Clinic
-
Wichita, Kansas, Forente stater, 37214-3199
- KU Medical School-Wichita, MPA
-
-
Louisiana
-
New Orleans, Louisiana, Forente stater, 70112-2699
- University of Mississippi Medical Center
-
New Orleans, Louisiana, Forente stater, 701122699
- Our Lady of the Lake Regional Med Ctr
-
New Orleans, Louisiana, Forente stater, 70112
- Louisiana Comm AIDS Rsch Prog / Tulane Univ Med
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02215
- Community Research Initiatives of New England
-
Boston, Massachusetts, Forente stater, 02215
- Community Research Initiatives/ProACT
-
Springfield, Massachusetts, Forente stater, 01107
- Community Research Initiative/ProACT
-
-
Michigan
-
Ann Arbor, Michigan, Forente stater, 48100-0378
- University of Michigan Health System
-
Detroit, Michigan, Forente stater, 48202
- Henry Ford Hosp
-
Detroit, Michigan, Forente stater, 48201
- Detroit Community Health Connection
-
Detroit, Michigan, Forente stater, 48201
- Detroit Receiving
-
Detroit, Michigan, Forente stater, 48201
- Wayne State Univ / Medical College of Ohio at Toledo
-
Detroit, Michigan, Forente stater, 48202
- Mt. Clemens General Hospital
-
Detroit, Michigan, Forente stater, 48202
- Providence Hosp- Newland Med Assoc. Inc.
-
Grand Rapids, Michigan, Forente stater, 49503
- McAuley Health Center
-
Lansing, Michigan, Forente stater, 48910
- Michigan State University Infectious Diseases Clinic
-
Royal Oak, Michigan, Forente stater, 48073
- William Beaumont Hospital/CORNET
-
-
Minnesota
-
Rochester, Minnesota, Forente stater, 55905
- Mayo Clinic/CORNET
-
-
New Jersey
-
Camden, New Jersey, Forente stater, 08103
- Cooper Hospital Early Intervention Program
-
Neptune, New Jersey, Forente stater, 07753
- Jersey Shore Med Ctr
-
Newark, New Jersey, Forente stater, 07103
- Jeffrey Bomser Clinic / NJCR
-
Newark, New Jersey, Forente stater, 071032842
- Raritan Bay Med Ctr
-
Newark, New Jersey, Forente stater, 071032842
- Saint Michael's Med Ctr
-
Newark, New Jersey, Forente stater, 07103
- New Jersey Community Research Initiative
-
Newark, New Jersey, Forente stater, 07103
- NJCRI
-
Somers Poinnt, New Jersey, Forente stater, 08244
- South Jersey Infectious Disease
-
-
New York
-
Bronx, New York, Forente stater, 10453
- Bronx-Lebanon Hosp Ctr
-
Bronx, New York, Forente stater, 10468
- Bronx Veterans Affairs Medical Center
-
Brooklyn, New York, Forente stater, 11023
- SUNY Downstate Med Ctr
-
New York, New York, Forente stater, 10037
- Grant Houses Health Ctr
-
New York, New York, Forente stater, 10037
- HHC MMC Unit #1
-
New York, New York, Forente stater, 10037
- HHC Outpatient Clinics
-
New York, New York, Forente stater, 10037
- Jacobi Medical Center
-
New York, New York, Forente stater, 10037
- Lenox Avenue Health Ctr
-
New York, New York, Forente stater, 10037
- Lincoln Medical & Mental Health Center
-
New York, New York, Forente stater, 10037
- Polo Grounds Health Care Ctr
-
New York, New York, Forente stater, 10037
- Syndenham Neighborhood Family Care Ctr
-
New York, New York, Forente stater, 10039
- Metropolitan Hospital Center
-
-
North Carolina
-
Winston-Salem, North Carolina, Forente stater, 27157-1042
- Wake Forest Univ Health Sciences
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73104
- Univ of Oklahoma Health Sciences
-
-
Oregon
-
Portland, Oregon, Forente stater, 97210
- The Research and Education Group
-
Portland, Oregon, Forente stater, 97209-2534
- Legacy Clinic NE
-
Portland, Oregon, Forente stater, 97209-2534
- Salem Hospital
-
Portland, Oregon, Forente stater, 972105311
- The Research & Education Group / Multomah Cnty Hlth Dept
-
Portland, Oregon, Forente stater, 972105311
- The Research & Education Group / The R & E Grp Office
-
Portland, Oregon, Forente stater, 972105311
- The Research & Education Grp / Oregon Hlth Sci Univ
-
Portland, Oregon, Forente stater, 972105311
- The Rsch & Ed Grp / Legacy Cln at Good Samaritan
-
Portland, Oregon, Forente stater, 972105311
- The Rsch & Ed Grp / Providence Portland Med Ctr
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19107
- Philadelphia FIGHT
-
Philadelphia, Pennsylvania, Forente stater, 19107
- Penn Community Infectious Diseases
-
Philadelphia, Pennsylvania, Forente stater, 19140
- Einstein Medical Center
-
Philadelphia, Pennsylvania, Forente stater, 19140
- Temple Univ School of Medicine
-
-
Texas
-
Houston, Texas, Forente stater, 77030
- Houston Veterans Administration Med Ctr
-
Houston, Texas, Forente stater, 77006
- Montrose Clinic
-
Houston, Texas, Forente stater, 77030
- Univ TX Health Science Ctr
-
Houston, Texas, Forente stater, 77030
- University Clinical Research Center
-
San Antonio, Texas, Forente stater, 78229
- South Texas Veterans Health Care System
-
-
Virginia
-
Lynchburg, Virginia, Forente stater, 24501
- Infectious Disease Associates of Virginia
-
Richmond, Virginia, Forente stater, 232980049
- Cross Over Clinic / Div of Infectious Diseases
-
Richmond, Virginia, Forente stater, 232980049
- McGuire VA / Division of Infectious Diseases
-
Richmond, Virginia, Forente stater, 23298
- MCV ID Clinic
-
Richmond, Virginia, Forente stater, 23298
- MediCorp, Infectious Disease Associates
-
Richmond, Virginia, Forente stater, 23298
- Petersburg Health Care Alliance
-
Richmond, Virginia, Forente stater, 23298
- South Richmond Health Ctr
-
Richmond, Virginia, Forente stater, 23298
- Vernon J. Harris East End Community Health Care Ct
-
-
Wisconsin
-
Madison, Wisconsin, Forente stater, 53792
- University Of Wisconsin Hospital and Clinics/CORNET, HIV Care Program
-
-
-
-
-
Annecy, Frankrike, 74011
- CHU de la Region Annecienne
-
Bordeaux, Frankrike, 33076
- Hôpital Pellegrin
-
Chu-grenoble, Frankrike
- Centre Hospitalier Universitaire
-
Colombes, Frankrike
- Hôpital Louis Mourier
-
Marseille, Frankrike, 13009
- Hôpital Sainte-Marguerite
-
Paris, Frankrike, 75651
- Hôpital Pitie Salpétrière
-
Paris, Frankrike, 75010
- Hôpital Saint-Louis
-
-
-
-
-
Dublin 8, Irland
- St. James Hospital
-
-
-
-
-
Tel Aviv, Israel, 64239
- Ramathibodi Hospital
-
-
-
-
-
Antella-Firenze, Italia, 50011
- U.O. Malattie Infettive, H.S.Maria Annunziata
-
Asti, Italia, 14100
- SOCDU Malattie Infettive Ospedale Civile Asti
-
Brescia, Italia, I-25125
- Instituto de Malattie Infettive e Tropicali
-
Busto Arsizio (va), Italia, 21052
- Malattie Infettive Busto
-
Modena, Italia, 41100
- Universita Degli Studi Di Modena E Reggio Emilia
-
Pavia, Italia, 27100
- Clinica Malattie Infettive
-
Rome, Italia, 00149
- I.R.C.C.S."L.Spallanzani"
-
Torino, Italia, 10149
- University of Turin
-
Torrette Di Ancona, Italia, 71-60020
- Servizio Regionale di Immunologia Clinica e Tipizz
-
Venice, Italia
- S.S. Giovanni e Paolo Hospital
-
-
-
-
-
Tokyo, Japan, 162-8655
- AIDS Medical Center, International Medical Center
-
Tokyo, Japan, 162-8655
- International Medical Center of Japan
-
-
-
-
-
Vilnius, Litauen, 03011
- Lithuanian AIDS center
-
-
-
-
-
Barble, Luxembourg, L-1210
- Centre Hospitalier de Luxembourg
-
-
-
-
-
Fort-de-france, Martinique, 97261
- C.H.U. Fort-de-France
-
-
-
-
-
Christchurch, New Zealand
- Christchurch Hosp
-
Wellington, New Zealand
- Wellington Hosp
-
-
-
-
-
Oslo, Norge, N-0407
- Ullevål hospital
-
-
-
-
-
Lima, Peru, 13
- Hospital Nacional Guillermo Almenara Irigoyen
-
Lima, Peru, 11
- Hospital Nacional Edgardo Rebagliati Martins
-
-
-
-
-
Koszarowa Str. 5, Polen
- Wroclaw University School of Medicine
-
-
-
-
-
Curitiba, Puerto Rico, 80430-040
- Instituto A. Z. de Pesquisa e Ensino
-
-
-
-
-
Barcelona, Spania, E08025
- Hospital de La Santa Creu i Sant Pau
-
Madrid, Spania, E-28006
- Hospital Universitario de La Princesa
-
Madrid, Spania, E-28805
- Hospital Universitario Príncipe de Asturias
-
Sevilla, Spania, 41013
- Hospital U. Virgen del Rocio
-
Terrassa, Spania, 08221
- Hospital Mútua de Terrassa
-
Valencia, Spania, 46014
- Consorcio Hospital General Universitario de Valencia
-
-
-
-
-
Belfast, Storbritannia, BT12 6BA
- Royal Victoria Hospital
-
Birmingham, Storbritannia, B9 5SS
- Hawthorn House, Birmingham Heartlands NHS Trust
-
Bristol, Storbritannia, BS10 5NB
- Southmead Hospital
-
Carshalton, Storbritannia, SM5, 1AA
- St. Helier Hospital
-
Carshalton, Surrey, Storbritannia, SM5, 1AA
- St. Helier Hospital
-
Essex, Storbritannia, CO3 3NB
- Essex County Hospital
-
Halifax, Storbritannia
- Victoria General Hospital, Q.E. II Health Sciences
-
London, Storbritannia, SW10 9NH
- Chelsea and Westminster Hospital
-
London, Storbritannia, NW3 2QG
- Royal Free Hospital
-
London, Storbritannia, SE1 7EH
- St. Thomas' Hospital
-
London, Storbritannia, E9 6SR
- Homerton University Hospital NHS Foundation Trust
-
London, Storbritannia, EC1A 7BE
- Barts and The London, NHS Trust
-
London, Storbritannia, NW10 7NS
- Central Middlesex Hospital
-
London, Storbritannia, SE5 9RS
- T1 Coleridge Unit, North Middlesex Hospital
-
London, Storbritannia, SE5 9RS
- The Caldecot Centre, Kings College Hospital NHS Tr
-
London, Storbritannia, SW17 ORE
- St. George's Hospital
-
London, Storbritannia, W1 2NY
- St. Mary's Hospital
-
London, Storbritannia, WC1E 6AU
- The Mortimer Market Center
-
Middlesbrough, Storbritannia, TS4 3BW
- The James Cook University Hospital
-
Middlesex, Storbritannia, UB1 3HW
- Pasteur Suite, Ealing Hospital
-
Newcastle, Storbritannia, NE4 6BE
- Newcastle General Hospital
-
Sheffield, Storbritannia, S10 2JF
- Dept. of Infection and Tropical Medicine - Royal Hallamshire Hospital
-
Watford Wd, Storbritannia, 18 0HB
- Watford Sexual Health Center;Watford General Hosp
-
-
England
-
Oxford, England, Storbritannia, OX3 9DU
- John Radcliffe Hospital
-
-
-
-
-
Basel Ch, Sveits, 4031
- University Hospital Basel
-
Bern, Sveits, 3010
- Poliklinik fur Infektiologie
-
La Chaux-de-Fonds, Sveits, 2300
- Hopital de la Ville
-
Lausanne, Sveits, 1011
- Centre Hospitalier Universitaire Vaudois (CHUV)
-
Lugano, Sveits, 6903
- Ospedale Regionale di Lugano
-
-
-
-
-
Chiang Mai, Thailand, 50120
- Sanpatong Hospital
-
Nonthaburi 11000, Thailand
- Bamrasnaradura Institute
-
-
-
-
-
Essen, Tyskland, 45122
- Klinik fur Dermatologie, Venerologie, Allergologie
-
Frankfort, Tyskland, 60590
- Johann Wolfgang Goethe University Hospital
-
Heidelberg, Tyskland, D-69115
- Klinikum der Ruprecht-Karis-Universitat (U. Hospital)
-
Zurich Ch-, Tyskland, 8091
- University Hospital Zurich
-
-
-
-
-
Vienna, Østerrike, A-1090
- University of Vienna Medical School, AKH
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Merk: Påmelding til denne prøveperioden ble stoppet 01/11/06.
Inklusjonskriterier:
- HIV-infeksjon
- CD4-celletall større enn 350 celler/mm3 innen 45 dager etter studiestart
- Villig til å starte, endre eller stoppe antiretroviral behandling
- Akseptable prevensjonsmetoder
- God helse ved studiestart
- Tilgjengelig for studiet i minst 6 måneder
- I stand til, etter klinikerens mening, å overholde protokollen
Ekskluderingskriterier:
- Deltar for tiden i MDR-HIV, NvR-studien eller en annen studie som ikke stemmer overens med en av behandlingsgruppene i denne studien. CPCRA FIRST-deltakere kan screenes for SMART etter 8. august 2005 og kan randomiseres til SMART på eller etter 19. september 2005.
- Gravid eller ammende
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Tidsperspektiver: Potensielle
Samarbeidspartnere og etterforskere
Etterforskere
- Studiestol: Wafaa El-Sadr, MD, MPH, Harlem AIDS Treatment Group, Harlem Hospital Center
- Studiestol: James Neaton, PhD, CPCRA Statistcal and Data Management Center / CCBR
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Lederman MM, Valdez H. Immune restoration with antiretroviral therapies: implications for clinical management. JAMA. 2000 Jul 12;284(2):223-8. doi: 10.1001/jama.284.2.223.
- Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000 Jan 19;283(3):381-90. doi: 10.1001/jama.283.3.381.
- Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, Lundgren JD. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet. 2000 Jul 22;356(9226):291-6. doi: 10.1016/s0140-6736(00)02504-6.
- Tebas P, Henry K, Mondy K, Deeks S, Valdez H, Cohen C, Powderly WG. Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies. J Infect Dis. 2002 Sep 15;186(6):851-4. doi: 10.1086/342603. Epub 2002 Aug 28. Erratum In: J Infect Dis 2002 Oct 15;186(8):1198.
- Yerly S, Kaiser L, Perneger TV, Cone RW, Opravil M, Chave JP, Furrer H, Hirschel B, Perrin L. Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study. AIDS. 2000 Feb 18;14(3):243-9. doi: 10.1097/00002030-200002180-00006.
- Borges AH, Neuhaus J, Sharma S, Neaton JD, Henry K, Anagnostou O, Staub T, Emery S, Lundgren JD; INSIGHT SMART; START Study Groups. The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis. J Infect Dis. 2019 Jan 7;219(2):254-263. doi: 10.1093/infdis/jiy442.
- Castillo-Mancilla JR, Phillips AN, Neaton JD, Neuhaus J, Collins S, Mannheimer S, Pett S, Touzeau-Romer V, Polizzotto MN, Lundgren JD, Gardner EM; INSIGHT SMART Study Group. Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study. Open Forum Infect Dis. 2017 Dec 22;5(1):ofx275. doi: 10.1093/ofid/ofx275. eCollection 2018 Jan.
- Larson GS, Carey C, Grarup J, Hudson F, Sachi K, Vjecha MJ, Gordin F; INSIGHT Group. Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials. Clin Trials. 2016 Apr;13(2):127-36. doi: 10.1177/1740774515625974. Epub 2016 Feb 8.
- Nordell AD, McKenna M, Borges AH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844.
- Lucas GM, Cozzi-Lepri A, Wyatt CM, Post FA, Bormann AM, Crum-Cianflone NF, Ross MJ; INSIGHT SMART Study Group. Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. HIV Med. 2014 Feb;15(2):116-23. doi: 10.1111/hiv.12087. Epub 2013 Sep 11.
- Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, Dalmau D, DeHovitz J, Lehmann C, Sullivan A, Woolley I, Kuller L, Neaton JD, Tracy RP; INSIGHT SMART Study Team. HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc. 2013 Jul 29;2(4):e000264. doi: 10.1161/JAHA.113.000264.
- Hoy J, Grund B, Roediger M, Ensrud KE, Brar I, Colebunders R, Castro ND, Johnson M, Sharma A, Carr A; INSIGHT SMART Body Composition Substudy Group. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. J Bone Miner Res. 2013 Jun;28(6):1264-74. doi: 10.1002/jbmr.1861.
- Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD; INSIGHT SMART Study Group. Platelet count kinetics following interruption of antiretroviral treatment. AIDS. 2013 Jan 2;27(1):59-68. doi: 10.1097/QAD.0b013e32835a104d.
- Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, Ross MJ, Wyatt CM; INSIGHT SMART Study Group; ESPRIT Study Group. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One. 2012;7(7):e40245. doi: 10.1371/journal.pone.0040245. Epub 2012 Jul 20.
- Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, Lampe FC, Liappis A, Friis-Moller N, Otvos J, Paton NI, Tracy R, Neaton JD; INSIGHT SMART Study Group. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. AIDS. 2011 Nov 13;25(17):2133-42. doi: 10.1097/QAD.0b013e32834be088.
- Mocroft A, Lifson AR, Touloumi G, Neuhaus J, Fox Z, Palfreeman A, Vjecha MJ, Hodder S, De Wit S, Lundgren JD, Phillips AN; INSIGHT SMART Study Group. Haemoglobin and anaemia in the SMART study. Antivir Ther. 2011;16(3):329-37. doi: 10.3851/IMP1746.
- Duprez DA, Neuhaus J, Tracy R, Kuller LH, Deeks SG, Orkin C, Stoehr A, Woolley IJ, Neaton JD; INSIGHT SMART Group. N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients. AIDS. 2011 Mar 13;25(5):651-7. doi: 10.1097/QAD.0b013e32834404a1.
- Lampe FC, Duprez DA, Kuller LH, Tracy R, Otvos J, Stroes E, Cooper DA, Hoy J, Paton NI, Friis-Moller N, Neuhaus J, Liappis AP, Phillips AN; INSIGHT SMART Study Group. Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy. J Acquir Immune Defic Syndr. 2010 Jul;54(3):275-84. doi: 10.1097/qai.0b013e3181d32158.
- Dore GJ, Soriano V, Rockstroh J, Kupfer B, Tedaldi E, Peters L, Neuhaus J, Puoti M, Klein MB, Mocroft A, Clotet B, Lundgren JD; SMART INSIGHT study group. Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption. AIDS. 2010 Mar 27;24(6):857-65. doi: 10.1097/QAD.0b013e328334bddb.
- Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, Gey D, Skoutelis A, Goetz MB, Phillips AN; INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis. 2009 Sep 15;200(6):973-83. doi: 10.1086/605447.
- Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC, Martinez E, Reiss P, Visnegarwala F, Carr AD; INSIGHT SMART Body Composition Substudy Group. Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009 Jul 31;23(12):1519-29. doi: 10.1097/QAD.0b013e32832c1792.
- Duprez DA, Kuller LH, Tracy R, Otvos J, Cooper DA, Hoy J, Neuhaus J, Paton NI, Friis-Moller N, Lampe F, Liappis AP, Neaton JD; INSIGHT SMART Study Group. Lipoprotein particle subclasses, cardiovascular disease and HIV infection. Atherosclerosis. 2009 Dec;207(2):524-9. doi: 10.1016/j.atherosclerosis.2009.05.001. Epub 2009 May 13.
- Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, Tracy R, Kuller L, Shlipak M, Angus B, Klinker H, Ross M; INSIGHT SMART Study Group. Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS. 2009 Jan 2;23(1):71-82. doi: 10.1097/QAD.0b013e32831cc129.
- Fox Z, Phillips A, Cohen C, Neuhaus J, Baxter J, Emery S, Hirschel B, Hullsiek KH, Stephan C, Lundgren J; SMART Study Group. Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS. 2008 Nov 12;22(17):2279-89. doi: 10.1097/QAD.0b013e328311d16f.
- Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD; SMART Study Group and International Network for Strategic Initiatives in Global HIV Trials (INSIGHT). Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis. 2008 Dec 1;47(11):1468-75. doi: 10.1086/593102.
- Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD; INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008 Oct 21;5(10):e203. doi: 10.1371/journal.pmed.0050203.
- SMART Study Group, El-Sadr WM, Grund B, Neuhaus J, Babiker A, Cohen CJ, Darbyshire J, Emery S, Lundgren JD, Phillips A, Neaton JD. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med. 2008 Sep 2;149(5):289-99. doi: 10.7326/0003-4819-149-5-200809020-00003.
- Strategies for Management of Anti-Retroviral Therapy/INSIGHT; DAD Study Groups. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS. 2008 Sep 12;22(14):F17-24. doi: 10.1097/QAD.0b013e32830fe35e.
- Gordin FM, Roediger MP, Girard PM, Lundgren JD, Miro JM, Palfreeman A, Rodriguez-Barradas MC, Wolff MJ, Easterbrook PJ, Clezy K, Slater LN. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med. 2008 Sep 15;178(6):630-6. doi: 10.1164/rccm.200804-617OC. Epub 2008 Jul 10.
- Phillips AN, Carr A, Neuhaus J, Visnegarwala F, Prineas R, Burman WJ, Williams I, Drummond F, Duprez D, Belloso WH, Goebel FD, Grund B, Hatzakis A, Vera J, Lundgren JD. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther. 2008;13(2):177-87. doi: 10.1177/135965350801300215.
- Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. J Infect Dis. 2008 Apr 15;197(8):1145-55. doi: 10.1086/529523.
- Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH, Palfreeman A, Wood R. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008 Apr 15;197(8):1133-44. doi: 10.1086/586713.
- Carr A, Grund B, Neuhaus J, El-Sadr WM, Grandits G, Gibert C, Prineas RJ; SMART Study Investigators. Asymptomatic myocardial ischaemia in HIV-infected adults. AIDS. 2008 Jan 11;22(2):257-67. doi: 10.1097/QAD.0b013e3282f20a77.
- Burman WJ, Grund B, Roediger MP, Friedland G, Darbyshire J, Wu AW; SMART Study Group. The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life. J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):185-93. doi: 10.1097/QAI.0b013e31815acaa4.
- Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fatkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006 Nov 30;355(22):2283-96. doi: 10.1056/NEJMoa062360.
Studierekorddatoer
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CPCRA 065
- SMART
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .